Anixa Biosciences Inc — Director's Dealing 2016

Oct 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-10-20

Reporting Person: HERMS HENRY P (VP, Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-20	Common Stock	M	2000	$2.575	Acquired	24125	Direct
2016-10-20	Common Stock	D	804	$6.4	Disposed	23321	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-20	Employee Stock Option	$2.575	M	2000	Disposed	2016-11-21	Common Stock (2000)	Direct

Footnotes

F1: The exercise of the option was net settled with the Company and 804 shares were withheld to pay the applicable exercise price pursuant to Section 16b-3(e) under the Securities Exchange Act of 1934, as amended.

F2: Right-To-Buy, pursuant to the ITUS Corporation 2003 Share Incentive Plan.